CENI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 5.889
EU - Europa 4.066
AS - Asia 2.317
SA - Sud America 338
AF - Africa 64
OC - Oceania 51
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.727
Nazione #
US - Stati Uniti d'America 5.835
RU - Federazione Russa 1.579
PL - Polonia 824
SG - Singapore 660
CN - Cina 575
HK - Hong Kong 427
IE - Irlanda 348
IT - Italia 344
SE - Svezia 334
BR - Brasile 282
KR - Corea 235
DE - Germania 192
VN - Vietnam 100
UA - Ucraina 98
IN - India 95
FI - Finlandia 94
GB - Regno Unito 87
JO - Giordania 73
FR - Francia 61
AU - Australia 51
CH - Svizzera 44
CA - Canada 26
AR - Argentina 25
ID - Indonesia 25
MO - Macao, regione amministrativa speciale della Cina 24
CI - Costa d'Avorio 23
BE - Belgio 21
JP - Giappone 21
BD - Bangladesh 16
ES - Italia 15
MX - Messico 15
TR - Turchia 15
IQ - Iraq 11
MA - Marocco 11
EC - Ecuador 9
NL - Olanda 9
ZA - Sudafrica 9
PK - Pakistan 7
EG - Egitto 5
LT - Lituania 5
TW - Taiwan 5
UY - Uruguay 5
VE - Venezuela 5
CO - Colombia 4
PH - Filippine 4
PY - Paraguay 4
SC - Seychelles 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GT - Guatemala 3
HN - Honduras 3
IL - Israele 3
KZ - Kazakistan 3
UZ - Uzbekistan 3
CL - Cile 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
NP - Nepal 2
PE - Perù 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AT - Austria 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DM - Dominica 1
ET - Etiopia 1
LK - Sri Lanka 1
LV - Lettonia 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
RO - Romania 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
Totale 12.727
Città #
Santa Clara 1.334
Warsaw 823
Ashburn 542
Fairfield 477
Singapore 442
Hong Kong 353
Dublin 348
Chandler 343
Woodbridge 262
Seoul 230
Cambridge 216
Seattle 206
Houston 188
Beijing 178
Wilmington 178
Jacksonville 164
Ann Arbor 143
Hefei 121
Lawrence 112
Buffalo 109
Altamura 106
Princeton 82
Munich 79
Los Angeles 75
Boardman 74
Dallas 74
Boston 68
Florence 65
Melbourne 51
The Dalles 48
Paris 46
New York 44
Mumbai 42
Shanghai 41
Bern 39
Moscow 37
Kent 34
São Paulo 33
San Diego 31
Ho Chi Minh City 30
Medford 29
Pune 27
Abidjan 23
Falls Church 23
Brussels 21
Hanoi 21
Bremen 20
Milan 20
Tokyo 20
Clifton 19
Jakarta 18
Turku 18
Dong Ket 16
Norwalk 16
Redondo Beach 16
London 14
West Jordan 14
Chicago 12
Helsinki 12
Phoenix 12
Yubileyny 12
Hillsboro 10
Izmir 10
Macao 9
Rio de Janeiro 9
Barcelona 8
Hanover 8
Andover 7
Casablanca 7
Chennai 7
Council Bluffs 7
Denver 7
Fiesole 7
Fontebuona 7
Orem 7
Poplar 7
Toronto 7
El Monte 6
Frankfurt am Main 6
Montreal 6
Ottawa 6
Secaucus 6
Auburn Hills 5
Brooklyn 5
Düsseldorf 5
Guangzhou 5
Haiphong 5
Porto Alegre 5
Rome 5
Stockholm 5
Bari 4
Bengaluru 4
Biên Hòa 4
Charlotte 4
Corigliano Calabro 4
Da Nang 4
Dhaka 4
Elk Grove Village 4
Hangzhou 4
Johannesburg 4
Totale 8.485
Nome #
2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma 333
Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling. 322
Magnetic hyperthermia and oxidative damage to dna of human hepatocarcinoma cells 306
8-Oxo-7,8-dihydro-2'-deoxyguanosine and other lesions along the coding strand of the exon 5 of the tumour suppressor gene P53 in a breast cancer case-control study. 286
Oxidative Stress in the Healthy and Wounded Hepatocyte: A Cellular Organelles Perspective 273
A new regulator of mitochondrial OXPHOS in hepatocytes and HCC cell lines: the AAA plus ATPase RuvBL1 226
NUCLEAR ORPHAN RECEPTOR COUP-TF2 INCREASED THE RESISTANCE TO ANIKOISIS AND THE METASTATIC POTENTIAL IN HEPATOCELLULAR CARCINOMA 220
Nuclear orphan receptor COUP-TF2 induces anoikis resistance, amoeboid migration and metastatic potential in hepatocellular carcinoma (HCC) 205
COUP-TFII in pancreatic adenocarcinoma: Clinical implication for patient survival and tumor progression. 202
A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cells 199
The orphan nuclear receptor COUP-TFII coordinates hypoxia-independent proangiogenic responses in hepatic stellate cells 192
Antidiabetic thiazolidinediones inhibit hepatic tumor formation in HBV transgenic mouse model. 192
Peroxisome-proliferator-activated receptor gamma (PPARgamma) is required for modulating endothelial inflammatory response through a nongenomic mechanism. 185
Acycloguanosyl 5'-thymidyltriphosphate, a Thymidine Analogue Prodrug Activated by Telomerase, Reduces Pancreatic Tumor Growth in Mice. 174
Acetaldehyde regulates the gene expression of matrix-metalloproteinase-1 and -2 in human fat-storing cells 173
Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro 172
Antidiabetic thiazolidinediones induce ductal differentiation but not apoptosis in pancreatic cancer cells. 171
Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: role of nitric oxide. 170
The AAA+ ATPase RuvBL1 localizes to mitochondria and supports HCC cell metabolism. 168
Alcohol induced hepatic fibrosis: role of acetaldehyde. 165
Liver haploinsufficiency of RuvBL1 causes hepatic insulin resistance and enhances hepatocellular carcinoma progression 162
Aldehyde Dehydrogenase-2 (aldh2) Gene Is Differently Expressed In Human Liver Fat-storing Cells (hfsc) and Liver-tissues 161
Acetaldehyde induces c-fos and c-jun proto-oncogenes in fat-storing cell cultures through protein kinase C activation 160
Hepatocyte-specific deletion of RuvBL1 leads to chronic liver damage and regeneration, enhancing HCC development 159
Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARgamma independent mechanisms 153
Induction of procollagen type I gene expression and synthesis in human hepatic stellate cells by 4-hydroxy-2,3-nonenal and other 4-hydroxy-2,3-alkenals is related to their molecular structure. 151
Isoforms of the orphan nuclear receptor COUP-TFII differentially modulate pancreatic cancer progression 150
Peroxisome proliferator-activated receptor gamma (PPARgamma) transcriptional activity is inhibited by acetaldehyde in human hepatic stellate cells (HSC) 148
Acetaldehyde induced collagen synthesis by inhibition of PPARgamma trascriptional activity via hydrogen peroxide-mediated activation of c-Abl non-receptor tyrosine kinase in human hepatic stellate cells 147
Telomerase activated thymidine analogue pro-drug is a new molecule targeting hepatocellular carcinoma 147
Acetaldehyde inhibits PPARgamma via H2O2-mediated c-Abl activation in human hepatic stellate cells. 144
The potential of antidiabetic thiazolidinediones for anticancer therapy. 143
Acetaldehyde inhibits peroxisome proliferator-activated receptor gamma (PPARg) transcriptional activity in hepatic stellate cells. A MAPk/pkcdelta-dependent mechanism. 143
In vivo effects of rosiglitazone in a human neuroblastoma xenograft 143
Intracellular signaling pathways activated by reactive oxygen species regulate proliferation and collagen synthesis of human hepatic stellate cells 141
RuvBL1 ATPase activity is essential for mitochondrial integrity and function in HCC cells 139
T.03.4 SPHINGOSINES, COUP-TFII AND PANCREATIC CANCER 138
Regulation of undulin synthesis and gene expression in human fat-storing cells by acetaldehyde and transfroming grwoth factor-B1 136
RuvBL1 haploinsufficiency improves mTOR-driven NASH-HCC development in mice 135
Apolipoprotein AI regulatory protein 1 (ARP-1) coordinates profibrogenic responses during liver fibrosis 133
Ruvbl1 regulates liver glucose metabolism via the Akt/mTOR pathway: Implications for hepatocellular carcinoma progression 133
Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis. 130
Telomerase Activated Thymidine Analogue Pro-drug Is A New Molecule Targeting Hepatocellular Carcinoma 130
A MITOCHONDRIAL ROLE FOR THE CANCER-RELATED AAA plus ATP-ASE RUVBL1 130
Thiazolidinediones inhibit growth and invasiveness of the human adrenocortical cancer cell line H295R 130
A N-TRUNCATED ISOFORM OF THE ORPHAN NUCLEAR RECEPTOR COUP-TFII MODULATES PANCREATIC CANCER PROGRESSION 129
PPARgamma activation by antidiabetic thiazolidinediones reduces liver fibrosis and hepatic stellate cells activation in vivo 129
A mitochondrial role of RuvBL1 ATPase in the regulation of HCC cell metabolism 128
Important Role of Sirt1 In the Survival and Activation of Hepatic Stellate Cells During Liver Injury 128
Neuropeptide-leukocyte interactions: examples of pharmacological modulation 127
Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells 127
Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor gamma-independent regulation of nucleophosmin. 126
P0244 : Thieno-triazolodiazepines block hepatocarcinoma progression by HSP-dependent kinoma inhibition 125
Targeting the AAA+ ATPase RuvBL1 reduces mTOR-driven NASH-HCC development in mice 124
Enanced responsiveness of ovalbumin-sensitized guinea-pig alveolar macrophages to tachykinins 124
Loss of hepatic RuvBL1 accelerates DEN-induced carcinogenesis due to chronic liver damage and regeneration 124
RUVBL1 correlates with chaperones expression in HCC and its activity is required for HSF1-mediated stress response 123
ANTAGONISTIC SIGNALLING BY PPARGAMMA AND ROSIGLITAZONE CONVERGE ON RUVBL1 REGULATION IN HCC CELLS 122
Genetics, alcohol, and cirrhosis 122
Ligation-mediated polymerase chain reaction detection of 8-oxo-7,8-dihydro-2′-deoxyguanosine and 5-hydroxycytosine at the codon 176 of the p53 gene of hepatitis c-associated hepatocellular carcinoma patients 119
Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production 117
CHRONIC PARTICULATE MATTER EXPOSITION REPRESENTS A SECOND HIT IN THE PROGRESSION FROM STEATOSIS TO STEATOHEPATITIS 116
Pathogenesis of alcoholic liver disease: Role of oxidative metabolism. 115
OC.05.6: TARGETING RUVBL1 REDUCES MTOR-DRIVEN NASH-HCC DEVELOPMENT IN MICE 113
Oxydative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism 112
Rosiglitazone reduces the in vitro and in vivo growth of HCC cell lines through a PPARgamma-independent inhibition of Ruvbl-1 111
THU-449-Nuclear orphan receptor COUP-TF2 increases the resistence to anoikis and induces amoeboid movment and metastatic potential in hepatocellular carcinoma 111
Pontin52 Is A Ppargamma Target Gene and Its Knockdown Reduces Hepatic Cancer In An Orthotopic-singenic Mouse Model 110
Evidence for tachykinin NK-2b-like receptors in guinea-pig alveolar macrophages. 109
THIENO-TRIAZOLODIAZEPINES BLOCK HEPATOCARCINOMA PROGRESSION BY HSP-DEPENDENT KINOMA INHIBITION 108
Therapeutic effects of a telomerase activated pro-drug, acycloguanosyl 5 '-thymidyltriphosphate, in hepatocellular carcinoma 107
Effect of pentoxifylline on the degradation of procollagen type I produced by human hepatic stellate cells in response to transforming growth factor-beta 1. 106
Loss of Hepatic RuvBL1 Causes Chronic Liver Damage and Regeneration, Promoting Hepatocellular Carcinoma 104
Human hepatic stellate cells express class I alcohol dehydrogenase and adlehyde dehydrogenase but not cytochrome P4502E1 102
RuvBL1 haploinsufficiency promotes hepatic lipid catabolism hampering NASH-HCC progression in mice 101
Peroxisome proliferator-activated receptor Gamma (PPAR Gamma) modulates hepatic stellate cells activation. 101
Paracrine cross-talk between pancreatic cancer cells and periacinar stellate cells enhanced tumor progression 99
Targeting RuvBL1 reduces mTOR-driven NASH-HCC progression in conditional PTEN-KO mice 96
Reactive oxigen species (ROS) modulate mitogenic and motogenic responses in human hepatic stellate cells 93
Helicobacter pylori infection modulates peroxisome proliferator activated receptor gamma (PPARgamma) expression and transcriptional activity. 93
THIAZOLIDINEDIONES INHIBIT HEPATIC TUMOUR FORMATION IN HBV TRANSGENIC MICE BY A PPAR gamma-INDEPENDENT REGULATION OF NUCLEOPHOSMIN 87
The orphan receptor COUP-TF II (Arp-1) is required for stellate cells activation and is involved in mitogenic responses in activated cells. 87
Peroxisome prolferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells 85
Tgf-beta Effects On the Synthesis of Extracellular-matrix Components By Human Fat-storing Cells Are Modulated By Different Matrices 81
SIRT1 ACTIVATION PREVENTS APOPTOSIS AND SENESCENCE OF HEPATIC STELLATE CELL DURING LIVER INJURY 80
Pentoxifylline causes degradation of procollagen I produced by human hepatic stellate cells in response to transforming growth factor-beta 1 76
Genetic polymorphisms in ethanol metabolizing enzymes do not influence the severity of alcoholic liver disease in Italian patients. 76
Oxidative stress induce collagen synthesis by c-Abl activation in human hepatic stellate cells 73
Tachykinins stimulate Lyso-PAF: acetyl-CoA Acetyltransferase activity in Neutrophils 69
Telomerase Activated Thymidine Analogue Prod-drug Prevents Growth and Induces Regression In Two In Vivo Models of Hepatocellular Carcinoma 64
The Impact of Peptidyl Arginine Deiminase 4-Dependent Neutrophil Extracellular Trap Formation on the Early Development of Intestinal Fibrosis in Crohn’s Disease 54
null 39
Totale 12.792
Categoria #
all - tutte 37.164
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.164


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021478 0 0 0 0 0 101 31 68 67 106 43 62
2021/2022558 22 49 23 33 25 24 23 29 23 26 127 154
2022/20231.619 125 317 76 139 99 279 205 82 203 6 39 49
2023/2024713 34 66 97 29 64 116 33 129 9 41 44 51
2024/20254.208 145 437 284 682 1.209 497 66 238 165 124 188 173
2025/20262.469 556 636 366 353 508 50 0 0 0 0 0 0
Totale 12.792